STRO (STOCKS)
Sutro Biopharma, Inc.
$29.000000
+2.810000 (+10.73%)
Prev close: $26.190000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Jane Chung
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $476.64M
- Employees
- 244
- P/E (TTM)
- -1.16
- P/B (TTM)
- -1.70
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
10
Buy
2
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-5.29 | $-4.43 | -0.8591 | -19.39% |
|
Sep 2025 (Q3)
|
$-6.70 | $-4.23 | -2.4727 | -58.49% |
|
Jun 2025 (Q2)
|
$-1.40 | $-4.10 | +2.7026 | +65.88% |
|
Mar 2025 (Q1)
|
$-9.10 | $-7.22 | -1.8835 | -26.10% |
Financial Statements
| Revenues | $102.48M |
| Benefits Costs and Expenses | $293.66M |
| Costs And Expenses | $293.66M |
| Operating Expenses | $260.85M |
| Research and Development | $166.42M |
| Other Operating Expenses | $94.43M |
| Operating Income/Loss | -$158.37M |
| Income/Loss From Continuing Operations After Tax | -$191.09M |
| Income/Loss From Continuing Operations Before Tax | -$191.18M |
| Income Tax Expense/Benefit | -$93.00K |
| Income Tax Expense/Benefit, Current | -$93.00K |
| Net Income/Loss | -$191.09M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$191.09M |
| Net Income/Loss Available To Common Stockholders, Basic | -$191.09M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$22.49 |
| Diluted Earnings Per Share | -$22.49 |
| Basic Average Shares | 8,497,798 |
| Diluted Average Shares | 8,497,798 |
| Assets | $173.83M |
| Current Assets | $150.93M |
| Noncurrent Assets | $22.90M |
| Fixed Assets | $10.65M |
| Other Non-current Assets | $12.26M |
| Liabilities | $306.28M |
| Current Liabilities | $75.13M |
| Accounts Payable | $7.57M |
| Other Current Liabilities | $67.57M |
| Noncurrent Liabilities | $231.15M |
| Equity | -$132.45M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$132.45M |
| Liabilities And Equity | $173.83M |
| Net Cash Flow From Operating Activities | -$177.23M |
| Net Cash Flow From Operating Activities, Continuing | -$177.23M |
| Net Cash Flow From Investing Activities | $45.01M |
| Net Cash Flow From Investing Activities, Continuing | $45.01M |
| Net Cash Flow From Financing Activities | $44.00K |
| Net Cash Flow From Financing Activities, Continuing | $44.00K |
| Net Cash Flow | -$132.17M |
| Net Cash Flow, Continuing | -$132.17M |
| Comprehensive Income/Loss | -$191.11M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$191.11M |
| Other Comprehensive Income/Loss | -$20.00K |